Congress Asset Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-6,268
Closed -$272K – 369
2021
Q1
$272K Buy
6,268
+115
+2% +$5.07K ﹤0.01% 340
2020
Q4
$264K Sell
6,153
-3,041
-33% -$111K ﹤0.01% 336
2020
Q3
$286K Buy
9,194
+554
+6% +$17.2K ﹤0.01% 316
2020
Q2
$276K Buy
8,640
+30
+0.3% +$996 ﹤0.01% 308
2020
Q1
$241K Buy
8,610
+2,905
+51% +$112K ﹤0.01% 313
2019
Q4
$263K Sell
5,705
-1,545
-21% -$72.6K ﹤0.01% 336
2019
Q3
$384K Buy
7,250
+2,825
+64% +$146K ﹤0.01% 321
2019
Q2
$234K Buy
+4,425
New +$235K ﹤0.01% 345

Other funds holding OFIX

Congress Asset Management's OFIX Position: Q2 2021 in Review

Congress Asset Management sold out of Orthofix Medical (OFIX) in Q2 2021, closing a stake of 6,268 shares — an estimated $272K sold.

Congress Asset Management first reported a position in OFIX in Q2 2019 and held it in 8 quarters. The position peaked at $384K in Q3 2019. 134 funds tracked by Wall St. Rank hold OFIX as of Q2 2021.

  • Congress Asset Management reported no remaining Orthofix Medical position as of Q2 2021 after selling out during the quarter.
  • Congress Asset Management sold 6,268 Orthofix Medical shares in Q2 2021, an estimated $272K.
  • Congress Asset Management first reported a position in Orthofix Medical in Q2 2019 and held it in 8 quarters.
  • Congress Asset Management's Orthofix Medical position peaked at $384K in Q3 2019.
  • 134 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2021.

Based on Congress Asset Management's 13F filing for Q2 2021, filed 5 Aug 2021.